van der Velden, D., Lagraauw, H. M., Wezel, A., Launay, P., Kuiper, J., Huizinga, T. W. J., . . . Stoop, J. N. (2016). Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile. Arthritis research & therapy, 18(1), 138. https://doi.org/10.1186/s13075-016-1036-8
Chicago-Zitierstil (17. Ausg.)van der Velden, Daniël, H. Maxime Lagraauw, Anouk Wezel, Pierre Launay, Johan Kuiper, Tom W. J. Huizinga, René E. M. Toes, Ilze Bot, und Jeroen N. Stoop. "Mast Cell Depletion in the Preclinical Phase of Collagen-induced Arthritis Reduces Clinical Outcome by Lowering the Inflammatory Cytokine Profile." Arthritis Research & Therapy 18, no. 1 (2016): 138. https://doi.org/10.1186/s13075-016-1036-8.
MLA-Zitierstil (9. Ausg.)van der Velden, Daniël, et al. "Mast Cell Depletion in the Preclinical Phase of Collagen-induced Arthritis Reduces Clinical Outcome by Lowering the Inflammatory Cytokine Profile." Arthritis Research & Therapy, vol. 18, no. 1, 2016, p. 138, https://doi.org/10.1186/s13075-016-1036-8.